Skip to content

Blood Glucose Test Strip GS300 and GS260

Evaluate the System Accuracy of Blood Glucose Test Strips GS300 and GS260

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033008
Enrollment
Unknown
Registered
2020-05-17
Start date
2020-06-01
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus

Interventions

Sponsors

Endocrinology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Male or female subjects aged 20 and 80 years; 2. Subjects who voluntarily participates the study and willing to comply with the study procedures and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients having any sever comorbidity within 6 months like stroke,acute myocardial infarction, leukemia, aplastic anemia, autoimmune disease and any other serious illness; 2. Subjects who have steroids medication, for example: Flixotide, Seretide 250, Serevent, Advair; 3. Notifiable bloodborne infectious diseases, for example:HIV,Treponema pallidum, HBV.

Design outcomes

Primary

MeasureTime frame
95% of the individual glucose results must be within ±0.83 mmol/L of the comparison-method results at glucose concentrations<5.5 mmol/Land within ±15% of the comparison-method results at glucose concentrations ? 5.5 mmol/L.;99% of individual glucose measured values shall fall within zones A and B.;GB;SEN, SPE, ACC, AUC of ROC, kappa value;

Countries

China

Contacts

Public ContactYufei Wang

Shanghai Sixth People's Hospital

13386259806@126.com+86 13386259806

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026